THE100NEWS

hindu.com | Feb. 12, 2024, 10:28 p.m.

U.S. FDA approves Aurobindo Pharma’s generic to treat Duchenne muscular dystrophy

| U.s. fda | Aurobindo pharma | Duchenne

economictimes.com | July 21, 2023, 2:11 a.m.

Aurobindo Pharma eyes $5-B revenue in 5 years

| Aurobindo pharma

economictimes.com | July 5, 2023, 7:03 a.m.

Stocks in news: LTIMindtree, Mankind Pharma, RBL Bank, Suzlon Energy, Aurobindo Pharma

| Mankind pharma | Rbl bank | Suzlon energy

economictimes.com | June 30, 2023, 7 a.m.

US FDA uncovers fresh faults at India's second-biggest drugmaker Aurobindo Pharma

| Us fda | India

economictimes.com | May 29, 2023, 7:18 a.m.

Stocks in news: Aurobindo Pharma, ONGC, Adani Transmission, IRCTC, Sun Pharma

| Aurobindo pharma | Ongc | Adani transmission | Irctc

economictimes.com | Feb. 28, 2023, 11:07 a.m.

Aurobindo Pharma shares rise 0.6% as Nifty drops

| Aurobindo pharma | Nifty

business-standard.com | Dec. 23, 2022, 8:11 a.m.

Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains

| Mehul kothari | Biocon | Aurobindo pharma

economictimes.com | Dec. 15, 2022, 12:49 p.m.

Share price of Aurobindo Pharma falls as Nifty weakens

| Share | Aurobindo pharma | Nifty

bqprime.com | Nov. 21, 2022, 1:37 p.m.

Aurobindo Pharma Telangana Facility Gets 10 USFDA Observations

| Aurobindo pharma shares fall | U.s. fda | Telangana

economictimes.com | Nov. 16, 2022, 9:24 a.m.

Buy Aurobindo Pharma, target price Rs 600: Centrum Broking

| Buy aurobindo pharma

economictimes.com | Nov. 14, 2022, 1:19 p.m.

Aurobindo Pharma shares tumble nearly 7% in early trade, hit 52-week low after Q2 earnings

| Aurobindo pharma

business-standard.com | Nov. 14, 2022, 9:45 a.m.

Aurobindo Pharma slips 7%, hits over 2-year low on weak Q2 results

| Aurobindo pharma

business-standard.com | Nov. 12, 2022, 7:50 p.m.

Aurobindo Pharma Q2 net down 41% to Rs 409 cr, revenue dips to Rs 5,739 cr

| Aurobindo pharma q2

bqprime.com | Nov. 12, 2022, 6:37 p.m.

Aurobindo Pharma Q2 Profit Falls 41%, Misses Estimates

| Aurobindo pharma q2 profit

scroll.in | Nov. 10, 2022, 9:03 p.m.

Delhi excise policy: ED arrests Aurobindo Pharma director, liquor company Pernod Ricard official

| Delhi | Aurobindo pharma | Pernod ricard

hindu.com | Nov. 10, 2022, 8:20 p.m.

Aurobindo Pharma shares tumble after arrest of director by ED

| Aurobindo pharma

bqprime.com | Nov. 10, 2022, 4:37 p.m.

Aurobindo Pharma Stock Falls To Its Lowest Since 2020

| Aurobindo pharma stock falls

business-standard.com | Nov. 10, 2022, 10:46 a.m.

Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED

| Aurobindo pharma | Sarath reddy

business-standard.com | Nov. 10, 2022, 10:44 a.m.

Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy

| Delhi

economictimes.com | Oct. 18, 2022, 1:24 p.m.

Shares of Aurobindo Pharma fall as Nifty gains

| Aurobindo pharma | Nifty

bqprime.com | Sept. 12, 2022, 2:21 p.m.

U.S. FDA Flags Three Procedural Lapses At Aurobindo Pharma’s Andhra Unit

| U.s. fda flags | Aurobindo pharma

business-standard.com | Sept. 1, 2022, 10:10 p.m.

Aurobindo Pharma's arm to invest around Rs 300 cr for capacity expansion

| Aurobindo pharma

business-standard.com | Aug. 29, 2022, 4 p.m.

Aurobindo Pharma subsidiary's plant gets one observation from USFDA

| Aurobindo pharma

business-standard.com | Aug. 16, 2022, 2:04 p.m.

USFDA approves Aurobindo Pharma owned Eugia's generic Vasopressin injection

| Usfda | Aurobindo pharma | Eugia

bqprime.com | Aug. 12, 2022, 6:52 a.m.

Adani Enterprises, Hero MotoCorp, Sterling And Wilson, Aurobindo Pharma, Apollo Hospitals Are In Focus Today

business-standard.com | Aug. 11, 2022, 8:22 p.m.

Aurobindo Pharma Q1 net profit down by 32% to Rs 520.5 cr; revenue up 9.4%

| Aurobindo pharma q1

bqprime.com | Aug. 11, 2022, 6:20 p.m.

Aurobindo Pharma's Q1 Profit Falls 32%

| Aurobindo pharma

economictimes.com | July 26, 2022, 1:19 p.m.

Aurobindo Pharma shares down 2.51% as Nifty falls

| Aurobindo pharma | Nifty

economictimes.com | July 25, 2022, 1:19 p.m.

Aurobindo Pharma stock price down 1.48 per cent as Sensex slides

| Aurobindo pharma | Sensex

business-standard.com | July 10, 2022, 1:09 p.m.

Aurobindo Pharma to develop complex products, expand global footprint

| Aurobindo pharma

economictimes.com | July 10, 2022, 12:33 p.m.

Aurobindo Pharma on track to develop complex products, expand global footprint

| Aurobindo pharma

bqprime.com | July 6, 2022, 12:41 p.m.

Live: Sensex, Nifty Rise; Aurobindo Pharma Extends Gains

| Nifty rise

business-standard.com | June 27, 2022, 5:54 p.m.

Aurobindo Pharma receives Sebi's warning letter over ongoing USFDA audit

| Aurobindo pharma | Sebi | Usfda

business-standard.com | June 3, 2022, 5:34 p.m.

Near-term growth issues and cost pressure could impact Aurobindo Pharma